Stem’s latest quarterly report reveals a company in the midst of a significant operational transformation. For Q3 2025, the energy storage specialist posted a 31% revenue surge to $38.2 million, marking the second consecutive quarter of positive adjusted EBITDA. Despite these fundamental improvements, investor sentiment remains cautious, with the stock price showing only a muted response to the news.
Profitability Metrics Show Dramatic Improvement
The most compelling evidence of Stem’s progress lies in its profitability metrics. The company achieved an adjusted EBITDA of $2.0 million, representing a substantial reversal from the $3.5 million loss recorded during the same period last year. Gross margins expanded significantly from 21% to 35%, while the net loss narrowed dramatically to $23.8 million from $148.3 million in the prior-year quarter.
Key financial highlights from the quarter include:
* Revenue: $38.2 million (31% year-over-year increase)
* Adjusted EBITDA: +$2.0 million (compared to -$3.5 million previous year)
* Operating cash flow: +$11.4 million (versus -$9.4 million prior year)
* Annual recurring revenue: $60.2 million (17% growth)
Should investors sell immediately? Or is it worth buying Stem?
Strategic Shift Presents Mixed Results
Behind these improved numbers lies a fundamental strategic pivot. Stem is deliberately shifting its focus toward higher-margin software solutions while reducing its exposure to low-margin hardware bookings. This transition comes with immediate trade-offs: total bookings declined sequentially to $30.3 million, and the company’s contracted backlog contracted to $22.2 million.
The market’s skepticism appears rooted in the company’s earnings performance. Despite operational improvements, Stem fell short of profit expectations, reporting a loss per share of $2.84.
Revised Guidance Signals Pragmatic Approach
Management’s updated full-year outlook reflects a more measured perspective on the company’s near-term prospects. Stem has narrowed its revenue guidance range to $135-$160 million and now anticipates adjusted EBITDA between -$5 million and +$5 million. These more conservative projections suggest heightened awareness of current market challenges, though questions remain about whether this realism will be sufficient to win over cautious investors.
Ad
Stem Stock: Buy or Sell?! New Stem Analysis from February 7 delivers the answer:
The latest Stem figures speak for themselves: Urgent action needed for Stem investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.
Stem: Buy or sell? Read more here...
